AEON Biopharma Inc. (AEON) Statistics & Valuation Metrics - Stocknear

AEON Biopharma Inc.

NASDAQ: AEON · Real-Time Price · USD
0.78
-0.00 (-0.33%)
At close: Sep 25, 2025, 3:59 PM
0.79
1.09%
After-hours: Sep 25, 2025, 07:37 PM EDT

AEON Biopharma Statistics

Share Statistics

AEON Biopharma has 11.64M shares outstanding. The number of shares has increased by 921.61% in one year.

11.64M
921.61%
7.34%
99.99%
8.2M
1,573
1.3%

Short Selling Information

The latest short interest is 155.88K, so 1.34% of the outstanding shares have been sold short.

155.88K
1.34%
1.34%
2.22

Valuation Ratios

The PE ratio is 0.01 and the forward PE ratio is null. AEON Biopharma's PEG ratio is 0.

0.01
n/a
0
n/a
-0.01
-0.01
0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for AEON Biopharma.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 0.11, with a Debt / Equity ratio of -0.45.

0.11
0.11
-0.45
-0.47
-0.64
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$8.4M
5
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -98.66% in the last 52 weeks. The beta is 0.71, so AEON Biopharma's price volatility has been higher than the market average.

0.71
-98.66%
0.76
6.7
53.67
120,728

Income Statement

n/a
n/a
72.98M
42.01M
-27.73M
-27.82M
5597.28
Full Income Statement

Balance Sheet

The company has 13K in cash and 12.96M in debt, giving a net cash position of -12.94M.

13K
12.96M
-12.94M
-431.6M
11.66M
1.13M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -20.29M and capital expenditures 0, giving a free cash flow of -20.29M.

-20.29M
n/a
-20.29M
-2703.8
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

AEON does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for AEON is $360, which is 46653.2% higher than the current price. The consensus rating is "Buy".

$360
46653.2%
Buy
1
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Feb 26, 2025. It was a backward split with a ratio of 1:72.

Feb 26, 2025
backward
1:72

Scores

-56.29
1